跳至主要内容
临床试验/EUCTR2005-000662-39-GB
EUCTR2005-000662-39-GB进行中(未招募)1 期

A 2x2 phase II randomized controlled trial to investigate the efficacy of NRT plus St John's wort versus NRT plus placebo in smoking cessation and to examine the efficacy of chromium nicotinate versus placebo in preventing weight gain while stopping smoking. - SJW and chromium in smoking cessation

Oxford Brookes University0 个研究点目标入组 144 人开始时间: 2005年8月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • All smokers 18 years or over that want to stop smoking and that have smoked at least 10 cigarettes per day for the past year. Clinically suitable to take NRT, SJW, and Cr.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Pregnant and breast feeding women, or women that are planning pregnancy while they would be scheduled to be on medication
  • 2) Severe liver impairment
  • 3) Current depression or recent moderate-severe depression (checked using the two screening questions recommended by NICE and by current use of antidepressant medication or past use during the past two years.
  • 4) People taking some antidepressants, antipsychotics, immunosupressants, digoxin, the pill, methadone (see exclusion list)

研究者

相似试验